Novo Nordisk A/S
Novo Nordisk A/S (NYSE: NVO) is trading at $38.31, about ₹3,680 at today's USD/INR rate, as of 29 Sep 2026, 3:59 PM ET, down 1.03% today. Indian residents can buy Novo Nordisk from India on Paasa under the RBI's Liberalised Remittance Scheme.
Quote
Today's low
$38.05
Today's high
$38.46
52 week low
$35.12
52 week high
$64.16
NVO opened at $38.46, closed previously at $38.71, and has traded between $35.12 and $64.16 over the past 52 weeks.
About
Novo Nordisk A/S is a global pharmaceutical firm dedicated to the investigation, creation, manufacturing, and distribution of medicinal products across a vast international footprint. Its market presence extends throughout Europe, the Middle East, Africa, various parts of Asia (including Mainland China, Hong Kong, and Taiwan), and North America. The company's operations are structured into two principal business units: Diabetes and Obesity Care, and Rare Disease. The Diabetes and Obesity Care division delivers therapies for diabetes, obesity, cardiovascular ailments, and other emerging therapeutic areas. Meanwhile, the Rare Disease division concentrates on providing treatments for rare blood disorders, uncommon endocrine conditions, and hormone replacement solutions. In addition to its core pharmaceutical offerings, Novo Nordisk produces specialized medical equipment such as insulin pens, growth hormone pens, and injection needles. It also pioneers smart digital solutions for diabetes management, including advanced insulin pens and the Dose Check application, designed to guide insulin dosage. The company engages in strategic alliances, notably a partnership with UNICEF to combat childhood obesity and a collaboration with Valo Health, Inc. to discover and advance novel drug pipelines in the cardiometabolic space. Founded in 1923, Novo Nordisk A/S is headquartered in Bagsvaerd, Denmark.
Key statistics
Avg. volume
12.47M
Market cap
$170.12B
P/E Ratio
9.51
Price-to-sales ratio
3.36
Enterprise value
DKK 1.54T
Free cash flow yield
2.01%
Debt-to-equity ratio
0.63
Return on equity
52.79%
ROIC
29.53%
Beta
0.35
Dividend yield
4.69%
Last dividend
$1.16
Financial overview
Revenue
DKK 309.06B
Earnings per share
DKK 23.06
Free cash flow
DKK 28.99B
Net profit margin
35.35%
Gross margin
80.65%
EBITDA
DKK 156.73B
Revenue growth
6.43%
Similar securities
This is not an investment recommendation
How to buy Novo Nordisk from India
Indian residents can buy Novo Nordisk shares through Paasa in four steps. Funds leave India under the RBI's Liberalised Remittance Scheme and the shares are held in your own name with Interactive Brokers.
Open a Paasa account
Complete digital KYC with your PAN, Aadhaar and address proof. Your brokerage account is opened in your own name with Interactive Brokers.
Add funds under LRS
Transfer INR from your Indian bank account. Your bank reports the remittance under the RBI's Liberalised Remittance Scheme and converts it to US dollars.
Search for Novo Nordisk and place an order
Find Novo Nordisk by name or by its ticker, NVO, and choose an order type. You can buy by amount or by quantity — fractional shares mean there is no minimum trade size. Novo Nordisk trades 7:00 pm – 1:30 am IST; orders can only execute during that window.
Track holdings and download tax reports
Follow your Novo Nordisk position in USD and INR, and use Paasa's capital-gains and dividend statements when you file your Indian return.
Read the full guide: how to invest in Novo Nordisk from India
Trading and taxes when buying Novo Nordisk from India
Trading and limits
- Trading hours
- 9:30 am – 4:00 pm ET
- LRS limit
- $250,000Per financial year, under the RBI's Liberalised Remittance Scheme.
Tax for Indian residents
- TCS on remittance
- 20%Collected by your bank on LRS remittances above ₹10 lakh in a financial year. The TCS is adjustable against your income-tax liability.Adjusting TCS against your tax
- Capital gains in India
- 12.5% or slab rateGains on shares held for more than 24 months are long-term and taxed at 12.5%. Gains on shares held for 24 months or less are short-term and taxed at your income-tax slab rate.Capital gains explained
- Dividends
- Slab rateDividends are taxed at your slab rate in India. Novo Nordisk’s current yield is 4.69%.Dividend tax explained
Custody. Shares are held in your own name at Interactive Brokers LLC and are SIPC-insured up to $500,000 in total, including $250,000 for cash.
FAQs
Can Indian residents buy Novo Nordisk stock?
Yes. Novo Nordisk (NVO) has been listed on the New York Stock Exchange since 1981, in the Drug Manufacturers - General industry, and Indian residents can buy it through Paasa. You fund the account from your Indian bank under the RBI's Liberalised Remittance Scheme and the money is converted to US dollars. Shares are held in your own name at Interactive Brokers LLC and are SIPC-insured up to $500,000 in total, including $250,000 for cash.
How much does one Novo Nordisk share cost in rupees?
One Novo Nordisk share is $38.31 — about ₹3,680 at a USD/INR rate of 96.06 on 29 Sep 2026. Both the Novo Nordisk price and the rupee rate move during the day, so the rupee cost changes with them.
What are the LRS and TCS rules for buying Novo Nordisk from India?
Remit up to $250,000 per financial year under the RBI's Liberalised Remittance Scheme (LRS). Banks collect 20% tax at source on LRS remittances above ₹10 lakh in a financial year; the TCS is adjustable against your income-tax liability. FX and the LRS declaration are handled by your bank when you fund your account.
Can I buy whole shares of Novo Nordisk?
Yes. One Novo Nordisk share is $38.31, and you can buy as many whole shares as you like. You can also buy by amount rather than by quantity: there is no minimum trade size, and Paasa supports fractional investing in Novo Nordisk.
How are gains on Novo Nordisk shares taxed in India?
The US does not levy capital gains tax on shares for Indian residents, so the tax is an India-side one. Gains on shares held for more than 24 months are long-term and taxed at 12.5%. Gains on shares held for 24 months or less are short-term and taxed at your income-tax slab rate. The gain is computed in rupees using the USD/INR rate on the purchase and the sale date, so the rupee move counts alongside the Novo Nordisk price. Paasa issues a capital-gains statement for your return.
Does Novo Nordisk pay a dividend, and how is it taxed in India?
Yes. Novo Nordisk pays a dividend and the current yield is 4.69%; the last declared dividend was $1.16 per share, about ₹111.77. Dividends are taxed at your slab rate in India. Paasa's dividend report lists the gross dividend and any tax withheld for each payment.
When can I trade Novo Nordisk from India?
The New York Stock Exchange trades 7:00 pm – 1:30 am IST in Indian time, so the close lands after midnight. The window shifts to 8:00 pm – 2:30 am IST when the US is on standard time. Orders can only execute during that window.
Is Novo Nordisk a United States company, and does that change how it is taxed?
Novo Nordisk trades on the New York Stock Exchange in US dollars, but the company is domiciled in Denmark. Novo Nordisk trades as an American Depositary Receipt rather than an ordinary share. Some non-US companies list in the US through American Depositary Receipts, which can carry dividend withholding at the company's home-country rate. Your India-side capital-gains treatment is the same either way.
Do I have to declare Novo Nordisk shares in my Indian tax return?
Yes. Foreign shares held on 31 March must be reported in Schedule FA of your Indian income-tax return. Paasa gives you a Schedule FA-ready statement listing your Novo Nordisk holding, its cost and its closing value.
How do I sell Novo Nordisk and bring the money back to India?
You sell during market hours (7:00 pm – 1:30 am IST) and the proceeds settle in USD in your Paasa account. From there you can hold the balance, reinvest, or repatriate. Funds can be withdrawn in any currency to any bank account in your own name. Whether the sale is short- or long-term is decided by the 24-month holding period.